Phuoc T. Tran, MD, PhD, is a Professor and Vice Chair for Research of Radiation Oncology at the University of Maryland. He is the Co-Leader of the Cancer Invasion and Metastasis Program in the Sidney Kimmel Comprehensive Cancer Center, and has an adjuvant appointments in Medical Oncology and Biochemistry and Molecular Biology Program at Johns Hopkins.  Phuoc is a board-certified radiation oncologist and clinically specializes in treatment of genitourinary (GU) malignancies.  His laboratory research funded by the NIH, DoD and foundations focuses on tumor cell epithelial plasticity programs, novel agents to enhance the local and systemic effects of radiation and the oligometastatic state, all to improve the outcomes of patients with cancer.  He also leads an active clinical trials program that includes interventional and translational investigator-initiated studies. He is the PI of one of the largest investigator initiated clinical trial examining the next generation AR-antagonist enzalutamide as a radiosensitizer for men with biochemical failure following surgery - SALV-ENZA.  He is the NRG Oncology GU Translational Science chair, ASTRO Research Funding Development Committee chair and a NCI RTB study section charter member.

Phuoc received his MD-PhD from OHSU, completed radiation oncology residency and postdoctoral fellowship at Stanford. Phuoc’s training focused on DNA repair, cancer biology, and transgenic mouse models. He joined the faculty of Johns Hopkins University in 2009 where he served as Clinical Director from 2015-2017 in Radiation Oncology before leaving for University of Maryland. He has received numerous awards for his research and clinical work from the RSNA, ASTRO, the Sidney Kimmel Foundation, the American Cancer Society, Uniting Against Lung Cancer, American Lung Association, the Movember Foundation, the Prostate Cancer Foundation and was voted a Top Doctor in Baltimore Magazine. He also serves as a Senior Editor/Editorial Board member for Cancer Research and the Journal of Clinical Oncology.